Exicure Inc (NASDAQ:XCUR) Stock In Focus Following Q1 Earnings Update

May 17, 2022

Early stage biotech firm Exicure Inc (NASDAQ:XCUR) was in the news yesterday but the news did not come as a boost for its stock, as it ended the day with a decline of as much as 6%. Trading Data On Monday, XCUR stock fell 6.20% to $.1151 with more than 12.90 million shares traded, compared to its average volume of 12.21 million shares. The stock moved within a range of…